Insider Transactions in Q3 2022 at Turning Point Therapeutics, Inc. (TPTX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2022
|
Paolo Tombesi EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,778
-100.0%
|
$2,263,128
$76.0 P/Share
|
|
Aug 17
2022
|
Brian Sun SVP & General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45,000
-100.0%
|
$3,420,000
$76.0 P/Share
|
|
Aug 17
2022
|
Steve M Sabus SVP & Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
36,667
-100.0%
|
$2,786,692
$76.0 P/Share
|
|
Aug 17
2022
|
Mohammad Hirmand EVP and Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,284
-100.0%
|
$3,137,584
$76.0 P/Share
|
|
Aug 17
2022
|
Simeon George Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,253,660
-100.0%
|
$171,278,160
$76.0 P/Share
|
|
Aug 17
2022
|
Athena Countouriotis President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
110,959
-100.0%
|
$8,432,884
$76.0 P/Share
|
|
Aug 17
2022
|
Mark J Alles Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,000
-100.0%
|
$152,000
$76.0 P/Share
|
|
Jul 27
2022
|
Paolo Tombesi EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,183
-3.96%
|
$87,542
$74.94 P/Share
|